I agree that this site is using cookies. You can find further informations here.
X
Jeffrey Schlom
580  results:
Search for persons X
?
1

Blood-based biomarkers in patients with non-small cell lung..:

Tsai, Yo-Ting ; Schlom, Jeffrey ; Donahue, Renee N.
Journal of Experimental & Clinical Cancer Research.  43 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
2

Hypothesis: the generation of T cells directed against neoe..:

Schlom, Jeffrey ; Donahue, Renee N ; Palena, Claudia...
Journal for ImmunoTherapy of Cancer.  12 (2024)  7 - p. e009595 , 2024
Link: https://doi.org/10.1136/..
 
?
3

Preclinical and clinical studies of a tumor targeting IL-12..:

Minnar, Christine M. ; Lui, Grace ; Gulley, James L...
Frontiers in Oncology.  13 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
4

Generation of murine tumor models refractory to αPD-1/-L1 t..:

Chariou, Paul L. ; Minnar, Christine M. ; Tandon, Mayank...
PLOS ONE.  19 (2024)  3 - p. e0287733 , 2024
Link: https://doi.org/10.1371/..
 
?
5

Efficacy, safety, and biomarker analyses of bintrafusp alfa..:

Rajan, Arun ; Abdul Sater, Houssein ; Rahma, Osama...
Journal for ImmunoTherapy of Cancer.  12 (2024)  3 - p. e008480 , 2024
Link: https://doi.org/10.1136/..
 
?
6

Soluble immune checkpoints: implications for cancer prognos..:

Pitts, Stephanie C. ; Schlom, Jeffrey ; Donahue, Renee N.
Journal of Experimental & Clinical Cancer Research.  43 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
7

Adjuvant nivolumab, capecitabine or the combination in pati..:

Lynce, Filipa ; Mainor, Candace ; Donahue, Renee N....
Nature Communications.  15 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
8

Author Correction: Adjuvant nivolumab, capecitabine or the ..:

Lynce, Filipa ; Mainor, Candace ; Donahue, Renee N....
Nature Communications.  15 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
9

Blockade of tumor-derived colony-stimulating factor 1 (CSF1..:

Maldonado, Maria del Mar ; Schlom, Jeffrey ; Hamilton, Duane H.
Cancer Immunology, Immunotherapy.  72 (2023)  10 - p. 3349-3362 , 2023
Link: https://doi.org/10.1007/..
 
?
10

Exploiting an Interleukin-15 Heterodimeric Agonist (N803) f..:

Lui, Grace ; Minnar, Christine M. ; Soon-Shiong, Patrick..
Cells.  12 (2023)  12 - p. 1611 , 2023
Link: https://doi.org/10.3390/..
 
?
11

Immune correlates with response in patients with metastatic..:

Toney, Nicole J. ; Gatti-Mays, Margaret E. ; Tschernia, Nicholas P....
International Immunopharmacology.  116 (2023)  - p. 109736 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Fulvestrant increases the susceptibility of enzalutamide-re..:

Dahut, Madeline ; Fousek, Kristen ; Horn, Lucas A...
Journal for ImmunoTherapy of Cancer.  11 (2023)  9 - p. e007386 , 2023
Link: https://doi.org/10.1136/..
 
?
13

Exploiting docetaxel-induced tumor cell necrosis with tumor..:

Franks, S. Elizabeth ; Santiago-Sanchez, Ginette S. ; Fabian, Kellsye P....
Cancer Immunology, Immunotherapy.  72 (2023)  8 - p. 2783-2797 , 2023
Link: https://doi.org/10.1007/..
 
?
14

An Interleukin-15 Superagonist Enables Antitumor Efficacy o..:

Fousek, Kristen ; Horn, Lucas A. ; Qin, Haiyan...
Journal of Thoracic Oncology.  18 (2023)  3 - p. 350-368 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Phosphoflow cytometry to assess cytokine signaling pathways..:

Toney, Nicole J. ; Schlom, Jeffrey ; Donahue, Renee N.
Journal of Experimental & Clinical Cancer Research.  42 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
1-15